ARWR:NASDAQ
Arrowhead Pharmaceuticals Inc
$59.57
arrow_downward
-0.55%(-0.33) 1D
$59.91
arrow_upward
+0.57% (+0.34)bedtimeAfter hours
Closed: Nov 2, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARWR...
Open
$60.55
High
$61.17
Low
$59.40
Mkt. cap
8.41B
Avg. vol.
1.85M
Volume
1.31M
52-wk high
$95.49
52-wk low
$37.06
EPS
-$2.24
Beta
1.30
Shares outstanding
141.25M
No. of employees
711
Open
$60.55
High
$61.17
Low
$59.40
Mkt. cap
8.41B
Avg. vol.
1.85M
Volume
1.31M
52-wk high
$95.49
52-wk low
$37.06
EPS
-$2.24
Beta
1.30
Shares outstanding
141.25M
No. of employees
711
News stories
From web sources and news partners
Seeking Alpha
·
14 minutes ago
Nasdaq And S&P 500 Index Lose Momentum, Pull Down Market
GreenevilleSun.com
·
17 minutes ago
More drops for AI and tech stocks overshadow gains for most of Wall Street
BeInCrypto
·
1 hour ago
Yardeni Says Analysts Still See S&P 500 Earnings Near $500 Per Share by 2028
Bloomberg.com
·
13 minutes ago
Nasdaq Slide Clouds Asian Open, Oil Falls on Iran: Markets Wrap
Profile
Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease. Wikipedia
About Arrowhead Pharmaceuticals Inc
CEOChristopher Richard Anzalone
Employees711
FoundedJan 1, 2004
HeadquartersPasadena, California, United States
SectorBiotechnology
Websitearrowheadpharma.com